ATG16L1 and inflammatory bowel disease: The potential epistasis signal between IRGM and ATG16L1 regarding CD susceptibility found in this study is highly interesting but could not been confirmed in a very large recent IBD meta-analysis [39] arguing against a major role of epistasis between IRGM and ATG16L1 regarding CD susceptibility.